Enter Your Email Address to Receive a
Copy of MedicExhange Member Demograhpics

Stryker Corporation announced that it will participate in the investor conference, March 9, 2010 – 3:20 p.m. Central Time, Canaccord Adams' Musculoskeletal Conference, New Orleans, LA.

A simultaneous webcast of the Company's presentation will be available on Stryker 's website at www.stryker.com.  The presentation for the Canaccord Adams' Musculoskeletal Conference will be archived for 30 days.

Certain statements made in the presentation may constitute forward-looking statements. They will be based upon management's current expectations and will be subject to various risks and uncertainties that could cause the Company's actual results to differ materially from those expressed or implied in such statements.

Such factors include, but are not limited to: weakening of economic conditions that could adversely affect the level of demand for the Company's products; pricing pressures generally, including cost-containment measures that could adversely affect the price of or demand for the Stryker 's products; changes in foreign exchange markets; legislative and regulatory actions; unanticipated issues arising in connection with clinical studies and otherwise that affect U.S. Food and Drug Administration approval of new products; changes in reimbursement levels from third-party payors; a significant increase in product liability claims; unfavorable resolution of tax audits; changes in financial markets; and changes in the competitive environment.

Additional information concerning these and other factors is contained in the Stryker 's filings with the U.S. Securities and Exchange Commission, including the Company's Annual Report on Form 10-K and Quarterly Reports on Form 10-Q.

Source: Stryker Corporation